U.S. Medicare program scales back hospice drugs restrictions

WASHINGTON Sat Jul 19, 2014 2:22am IST

U.S. President Barack Obama meets with health insurance chief executives at the White House in Washington November 15, 2013.  REUTERS/Kevin Lamarque

U.S. President Barack Obama meets with health insurance chief executives at the White House in Washington November 15, 2013.

Credit: Reuters/Kevin Lamarque

Related Topics

WASHINGTON (Reuters) - The Obama administration on Friday backed down on restrictions of private insurance coverage for hospice drugs under Medicare, saying the regulations were preventing some terminally ill patients from having access to medicine.

The Centers for Medicare and Medicaid Services (CMS) said it would now require prior-approval for coverage of only four categories of drugs: analgesics, anti-nauseants, laxatives and anti-anxiety drugs. In a regulation announced in March, the government had required prior approval for all hospice drugs under the Medicare Part D prescription drug benefit.

“Based on discussions with stakeholders, we are adjusting our rules so that beneficiaries enrolled in hospice will continue to have access to their medications,” CMS spokesman Raymond Thorn said in a statement.

The change follows a June meeting between officials and stakeholders including hospice providers, insurers and pharmacies and patient advocates who described the operational challenges of requiring all hospice drugs to be approved before they could be dispensed.

On Friday, the agency acknowledged in a memo to stakeholders that the March regulations were causing difficulties and "in some cases, barriers to access for beneficiaries."  

CMS issued the initial rule after an investigation by the Department of Health and Human Services found that the Medicare program for the elderly and disabled were paying twice for some drugs.

Under Medicare's Part A hospital program, hospices receive daily payments for each patient but are responsible for all drugs related to a patient's terminal illness. Medicare Part D covers only prescriptions and medications for curative conditions that are unrelated to a terminal illness.

The four groups of drugs that remain subject to the restriction are generally used to relieve discomfort in patients near the end of life. CMS said it expects Part D claims for those treatments to be very few, but said it would provide coverage under the program if a provider simply stated that they were "unrelated" to the patient's terminal illness.

(Reporting by David Morgan; Editing by Lisa Shumaker)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

HEALTH SHOWCASE

Breast Cancer Fight

Breast Cancer Fight

Roche, Merck extend immunotherapy fight to breast cancer  Full Article 

Office Perks

Office Perks

Apple, Facebook will pay for female employees to freeze their eggs.  Full Article 

It's In The Genes

It's In The Genes

Genetic link to Danish happiness, says study.  Video 

Smoking Effects

Smoking Effects

Americans have 14 million smoking-related ailments: study.  Full Article 

Health Food

Health Food

Olive oil, nuts may help reverse heart risk factors.  Full Article 

Digital Doctors

Digital Doctors

China sees tech cure for healthcare woes.  Full Article 

Stem Cell Study

Stem Cell Study

Stem cells from human embryos prove safe, improve vision - study.  Full Article 

Shortages Impact

Shortages Impact

Shortages hinder Venezuela's battle against fever outbreaks  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage